Lost Money on Pacira BioSciences, Inc. (PCRX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Portfolio Pulse from
Levi & Korsinsky has started an investigation into Pacira BioSciences, Inc. (NASDAQ:PCRX) for potential violations of federal securities laws. This follows a press release by Pacira on August 9, 2024, regarding a lawsuit outcome against eVenus for patent infringement.
January 10, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pacira BioSciences is under investigation by Levi & Korsinsky for potential securities law violations. This comes after a lawsuit result against eVenus for patent infringement.
The investigation by Levi & Korsinsky into potential securities law violations could negatively impact investor confidence in Pacira BioSciences. Legal issues often lead to stock price volatility, and the outcome of the investigation could have financial implications for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100